Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer
Applying to UC Irvine Health/Chao Family Comprehensive Cancer Center · Orange, California
Answer a few short questions to share with the research team.